Efficacy of acupuncture versus sham acupuncture on generalized anxiety disorder: a meta-analysis of randomized controlled trials.

Researchers conducted a comprehensive review to determine whether acupuncture provides real benefits for generalized anxiety disorder (GAD) beyond placebo effects. They analyzed 14 randomized controlled trials involving 968 adults with GAD, comparing real acupuncture to sham acupuncture (a placebo control where needles don't penetrate fully or are placed at non-therapeutic locations).

The study found that real acupuncture was significantly more effective than sham acupuncture across multiple measures. Patients receiving genuine acupuncture experienced meaningful reductions in anxiety symptoms on the Hamilton Anxiety Scale, with an average improvement of 2.71 points. They also showed better outcomes on self-reported anxiety measures, improved sleep quality, and reduced depression symptoms. The research even detected biological changes, with lower levels of stress hormones (cortisol and ACTH) in the acupuncture groups.

While the improvements were modest rather than dramatic, they demonstrate that acupuncture produces specific therapeutic effects beyond placebo for GAD. The benefits extended to sleep quality and mood, suggesting acupuncture may address multiple aspects of anxiety disorders. However, the researchers noted that the quality of evidence varied from low to moderate, and there were differences in how studies were conducted.

For patients considering acupuncture for anxiety, these findings are encouraging. Acupuncture appears to be a viable non-drug option that can meaningfully reduce anxiety symptoms, though it may work best as part of a comprehensive treatment approach. To maximize benefits, seek treatment from a licensed acupuncturist with experience treating anxiety disorders.

This meta-analysis evaluated acupuncture versus sham acupuncture for generalized anxiety disorder across 14 RCTs (n=968). Acupuncture demonstrated statistically significant improvements in HAMA scores (MD=-2.71, 95% CI -4.17 to -1.25, p=0.0003), representing modest but clinically relevant anxiety reduction. Secondary outcomes showed improvements in SAS (MD=-9.33), GAD-7 (MD=-2.99), PSQI (MD=-2.83), and SDS (MD=-11.40), all statistically significant. Biological markers revealed small effects on cortisol (SMD=-0.33) and ACTH (MD=-3.18). High heterogeneity characterized most outcomes, and GRADE assessment rated evidence certainty as low to very low for patient-reported measures and moderate for biomarkers. Clinical takeaway: Acupuncture produces specific therapeutic effects beyond placebo for GAD patients, supporting its use as an evidence-based adjunct or alternative to pharmacotherapy, though standardized treatment protocols require further investigation to optimize clinical outcomes.